Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
About TRANSCEND-T2D-1 and the TRANSCEND-T2D clinical trial program TRANSCEND-T2D-1 (NCT06354660) is a Phase 3, 40-week, randomized, double-blind, placebo-controlled study comparing the efficacy and safety of retatrutide with placebo in adults with type 2 diabetes and inadequate glycemic control with diet and exercise alone
Each treatment is medically supervised and supported by real human experts for accountability and long-term success
Why is Wegovy more expensive than Ozempic if they contain the same ingredient
Heartburn and dyspepsia occur in approximately 3-9% of patients taking GLP-1 medications according to clinical trial data
US$ 25.57
US$ 26.14
US$ 25.39
US$ 21.63
US$ 21.61
US$ 22.90
US$ 27.47
